tiprankstipranks
Advertisement
Advertisement

ELVN Stock Latest News

Enliven price target raised to $67 from $59 at Goldman Sachs
The FlyEnliven price target raised to $67 from $59 at Goldman Sachs
15d ago
ELVN
Enliven price target raised to $65 from $56 at H.C. Wainwright
PremiumThe Fly
Enliven price target raised to $65 from $56 at H.C. Wainwright
27d ago
ELVN
Enliven price target raised to $80 from $60 at Stifel
PremiumThe Fly
Enliven price target raised to $80 from $60 at Stifel
1M ago
ELVN
Enliven price target raised to $70 from $45 at JonesResearch
PremiumThe Fly
Enliven price target raised to $70 from $45 at JonesResearch
1M ago
ELVN
Enliven Therapeutics Prices Upsized Public Equity Offering
PremiumCompany Announcements
Enliven Therapeutics Prices Upsized Public Equity Offering
2M ago
8K
ELVN
Why Is Enliven Therapeutics Stock (ELVN) Up Today?
PremiumMarket NewsWhy Is Enliven Therapeutics Stock (ELVN) Up Today?
2M ago
ELVN
Enliven rises 9.9%
Premium
The Fly
Enliven rises 9.9%
2M ago
ELVN
Enliven 8.9M share Spot Secondary priced at $37.50
Premium
The Fly
Enliven 8.9M share Spot Secondary priced at $37.50
2M ago
ELVN
Enliven announces $250M common stock offering
PremiumThe Fly
Enliven announces $250M common stock offering
2M ago
ELVN
Midday Fly By: Oracle slides, SpaceX on deck for public debut
PremiumThe Fly
Midday Fly By: Oracle slides, SpaceX on deck for public debut
2M ago
GD
MH
Boris Peaker Reiterates Buy Rating and $45 Price Target on ELVN-001 After Strong Phase 1b CML Data Support Best-in-Class Potential
PremiumRatings
Boris Peaker Reiterates Buy Rating and $45 Price Target on ELVN-001 After Strong Phase 1b CML Data Support Best-in-Class Potential
2M ago
ELVN
Enliven rises 14.8%
PremiumThe Fly
Enliven rises 14.8%
2M ago
ELVN
Enliven advances ELVN-001 with positive Phase 1 data
PremiumCompany AnnouncementsEnliven advances ELVN-001 with positive Phase 1 data
2M ago
8K
ELVN
Enliven up 15% to $42.50 after positive data from Phase 1 ENABLE trial
Premium
The Fly
Enliven up 15% to $42.50 after positive data from Phase 1 ENABLE trial
2M ago
ELVN
Enliven’s ELVN-001 shows efficacy in Phase 1 myeloid leukemia trial
Premium
The Fly
Enliven’s ELVN-001 shows efficacy in Phase 1 myeloid leukemia trial
2M ago
ELVN
Enliven Therapeutics Expands Authorized Shares After Stockholder Vote
PremiumCompany Announcements
Enliven Therapeutics Expands Authorized Shares After Stockholder Vote
2M ago
8K
ELVN
Toll Brothers upgraded, Lennar downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Toll Brothers upgraded, Lennar downgraded: Wall Street’s top analyst calls
2M ago
AJG
AVB
Enliven initiated with a Buy at Stifel
PremiumThe Fly
Enliven initiated with a Buy at Stifel
2M ago
ELVN
Analyst Raises Price Target to $59 and Reaffirms Buy on ELVN-001’s Differentiated CML Opportunity
PremiumRatings
Analyst Raises Price Target to $59 and Reaffirms Buy on ELVN-001’s Differentiated CML Opportunity
2M ago
ELVN
Enliven price target raised to $62 from $45 at Mizuho
PremiumThe FlyEnliven price target raised to $62 from $45 at Mizuho
2M ago
ELVN
Boris Peaker Reiterates Buy Rating on ELVN-001 with Unchanged $45 Price Target, Citing Strong Clinical Data and Strategic Positioning
Premium
Ratings
Boris Peaker Reiterates Buy Rating on ELVN-001 with Unchanged $45 Price Target, Citing Strong Clinical Data and Strategic Positioning
3M ago
ELVN
Enliven to presents Phase 1 clinical trial data for ELVN-100 at EHA Congress
Premium
The Fly
Enliven to presents Phase 1 clinical trial data for ELVN-100 at EHA Congress
3M ago
ELVN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >